Fat fuels aggressive brain cancers
Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.
Oct 19, 2018
0
4
Fat is powering tumour growth in brain cancer, finds a new study by Cardiff University and the University of Florida.
Oct 19, 2018
0
4
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...
Oct 19, 2018
0
147
Surgeons could soon eavesdrop on a patient's brain activity during surgery to remove their brain tumour, helping improve the accuracy of the operation and reduce the risk of impairing brain function.
Oct 16, 2018
0
8
Walter and Eliza Hall Institute researchers have genetically engineered a new laboratory model that enables accurate testing of anti-cancer drugs by mimicking the complexity of human cancers.
Oct 11, 2018
0
9
Resistance to therapy is a major problem in cancer patients, as resistant cells are at the root of tumour relapse and are associated with high morbidity and mortality. A better understanding of the mechanisms associated with ...
Oct 10, 2018
0
22
Nearly 1 in 4 patients with advanced cancer, treated at Comprehensive Cancer Care Network (NCCN) centres in the US, are receiving innovative drugs matched to DNA mutations in their tumours. This achievement, to be reported ...
Oct 9, 2018
0
1
Choosing the correct individualised treatment for breast cancer depends upon determination of receptors for oestrogen, progesterone and HER2. The gold-standard method is currently immunohistochemistry (IHC). However, in 5 ...
Oct 9, 2018
0
1
Individuals with an inherited form of skin cancer often have a poor prognosis. The type of immunotherapy that was awarded this year's Nobel Prize in Physiology or Medicine is, however, particularly effective in this patient ...
Oct 8, 2018
0
16
Not so long ago, immunotherapy against cancer was positioned as an emerging or even promising treatment, but not one with a proven track record. Today however, novel immunotherapeutics across different tumor types, either ...
Oct 3, 2018
0
128
The presence of the human high-risk papillomavirus (hrHPV) in the diagnosis of invasive cervical cancer is linked to a greatly improved prognosis compared to cases in which hrHPV cannot be identified in the tumour, according ...
Oct 3, 2018
0
0